Knowing your hepatitis C status has no apparent effect on the likelihood of your developing advanced liver fibrosis.

A new immune therapy targeting hepatitis B has shown promise in an animal study.

With a quarter of Americans living with the condition, fatty liver disease is increasingly a cause of liver cancer.

Researchers have identified a new therapy that could help treat liver cancer in a certain subset of people with the disease.

An investigational anti-diabetes drug may be an option for treating NASH and NAFLD.

Various combinations of Sovaldi, Olysio and ribavirin can cure hepatitis C among those with decompensated cirrhosis.

Daclatasvir and Sovaldi, with or without ribavirin, seem likely to lead to relatively good cure rates among people with genotype 3 of hepatiti...

Daclatasvir and Sovaldi, with or without ribavirin, offer near-perfect hepatitis C cure rates among those who have received a liver transplant...

People with hepatitis C are at increased risk of cardiovascular disease.

A significant proportion of people with undiagnosed hepatitis C likely have advanced liver disease and are in relatively urgent need of treatm...